Evidence map›Paper›PMID 21170271›Full record

ArticlePloS one2010

Cellular reactive oxygen species inhibit MPYS induction of IFNβ.

Lei Jin, Laurel L Lenz, John C Cambier

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Activation and regulation of DNA-driven immune responses.Microbiology and molecular biology reviews : MMBR · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lei JinIntegrated Department of Immunology, University of Colorado Denver School of Medicine and National Jewish Health, Denver, Colorado, United States of America.
Laurel L Lenz
John C Cambier
University of Colorado Denver · US

Funding

Immune Modulation by Bacterial AutolysinsR01AI065638 · NIAID · UNIVERSITY OF COLORADO DENVER · PI LENZ, LAUREL L · 2006 to 2016
$3.8M
NKIP signaling and functionsR01AI062739 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C · 2005 to 2009
$2.2M
NIAID NIH HHS 3R01AI062739-05S209NIAID NIH HHS 5R01AI062739-05NIAID NIH HHS 5R01AI065638-04NIAID NIH HHS R01 AI062739NIAID NIH HHS R01 AI065638
6 · The paper itself

Abstract

Many inflammatory diseases, as well as infections, are accompanied by elevation in cellular levels of Reactive Oxygen Species (ROS). Here we report that MPYS, a.k.a. STING, which was recently shown to mediate activation of IFNβ expression during infection, is a ROS sensor. ROS induce intermolecular disulfide bonds formation in MPYS homodimer and inhibit MPYS IFNβ stimulatory activity. Cys-64, -148, -292, -309 and the potential C₈₈xxC₉₁ redox motif in MPYS are indispensable for IFNβ stimulation and IRF3 activation. Thus, our results identify a novel mechanism for ROS regulation of IFNβ stimulation.

Indexed as

AnimalsCell LineCysteineDimerizationDisulfidesGenes, ReporterHumansInterferon-betaInterferon Regulatory Factor-3Listeria monocytogenesMembrane ProteinsMiceMutationReactive Oxygen SpeciesSTING ProteinCysteineDisulfidesInterferon-betaInterferon Regulatory Factor-3IRF3 protein, humanIrf3 protein, mouseMembrane ProteinsReactive Oxygen SpeciesSTING1 protein, humanSTING Protein

Identifiers

PMID21170271
PMCPMC3000824
OpenAlexW2075855311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.